We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
Cap. Flow
+$670M
Cap. Flow %
14.88%
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118

Sector Composition

Rank Sector Weight
1 Healthcare 13.99%
2 Industrials 12.65%
3 Financials 10.63%
4 Consumer Discretionary 9.16%
5 Energy 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEX icon
226
Terex
TEX
$7.76B
$5.15M 0.11%
125,390
-307,787
-71% -$12.5M
GNMK
227
DELISTED
GenMark Diagnostics, Inc
GNMK
$5.15M 0.11%
380,896
-1,828
-0.5% -$19.1K
DD icon
228
DuPont de Nemours
DD
$19.6B
$5.14M 0.11%
+39,427
New +$5.02M
RBBN icon
229
Ribbon Communications
RBBN
$379M
$5.13M 0.11%
285,655
-29,023
-9% -$491K
SGNT
230
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$5.12M 0.11%
+197,859
New +$4.39M
CRI icon
231
Carter's
CRI
$1.47B
$5.11M 0.11%
+74,196
New +$5.39M
AMID
232
DELISTED
American Midstream Partners, LP
AMID
$5.05M 0.11%
175,000
DHI icon
233
D.R. Horton
DHI
$41.8B
$4.92M 0.11%
+200,000
New +$4.57M
FNF icon
234
Fidelity National Financial
FNF
$13.6B
$4.91M 0.11%
+262,729
New +$4.92M
IBTX
235
DELISTED
Independent Bank Group, Inc.
IBTX
$4.84M 0.11%
86,948
+7,743
+10% +$408K
TAST
236
DELISTED
Carrols Restaurant Group, Inc.
TAST
$4.8M 0.11%
+674,665
New +$4.67M
FSL
237
CALL
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
$4.76M 0.11%
202,400
-231,100
-53% -$5.36M
HLT icon
238
Hilton Worldwide
HLT
$71.6B
$4.68M 0.1%
+67,024
New +$4.46M
ATRC icon
239
AtriCure
ATRC
$2.06B
$4.65M 0.1%
252,907
+3,597
+1% +$59.9K
CNX icon
240
CNX Resources
CNX
$5.21B
$4.63M 0.1%
120,574
+8,027
+7% +$294K
TPVG icon
241
TriplePoint Venture Growth BDC
TPVG
$212M
$4.59M 0.1%
280,177
+76,417
+38% +$1.18M
JCP
242
DELISTED
J.C. Penney Company, Inc.
JCP
$4.48M 0.1%
+494,647
New +$4.26M
X
243
DELISTED
US Steel
X
$4.43M 0.1%
170,000
+57,615
+51% +$1.47M
MBII
244
DELISTED
Marrone Bio Innovations, Inc.
MBII
$4.4M 0.1%
378,471
+111,480
+42% +$1.26M
ATVI
245
DELISTED
Activision Blizzard
ATVI
$4.35M 0.1%
+194,875
New +$4.01M
GPRO icon
246
GoPro
GPRO
$123M
$4.31M 0.1%
+106,191
New +$3.81M
PLUS icon
247
ePlus
PLUS
$2.35B
$4.2M 0.09%
+288,836
New +$4.01M
CEQP
248
DELISTED
Crestwood Equity Partners LP
CEQP
$4.16M 0.09%
27,980
+8,024
+40% +$1.12M
PEGI
249
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$4.12M 0.09%
+124,468
New +$3.64M
JNPR
250
CALL
DELISTED
Juniper Networks
JNPR
$4.09M 0.09%
166,700
-24,900
-13% -$619K

Similar funds

Alyeska Investment Group's Q2 2014 Portfolio in Review

As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.

  • Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
  • Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
  • Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
  • Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
  • Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
  • Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.

Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.